The Scoping Study was released 3 months ago with no significant news flow since then so we can only assume they have been advancing the PFS since then. A H1 2023 PFS release expectation is not outrageous.
AP completely lost my trust and RR has my trust until he loses it by non performance. I am, however, not going to vote for him to get generous Performance Rights unless he maps out the future with an aggressive but achievable Gaant chart of 2023 milestones. I am confident that he will map out a pathway to success before the upcoming General Meeting. If he does not he has lost my vote and I suggest you all join me in that vote.
RXL Price at posting:
18.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)